Spero Therapeutics, Inc. (SPRO)
1.19
-0.07
(-5.56%)
USD |
NASDAQ |
Oct 02, 16:00
1.195
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Market Cap : 69.19M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 69.19M |
| October 01, 2026 | 73.27M |
| September 30, 2026 | 70.36M |
| September 29, 2026 | 69.78M |
| September 28, 2026 | 69.19M |
| September 25, 2026 | 71.52M |
| September 24, 2026 | 72.68M |
| September 23, 2026 | 73.27M |
| September 22, 2026 | 79.08M |
| September 21, 2026 | 66.29M |
| September 18, 2026 | 65.71M |
| September 17, 2026 | 65.12M |
| September 16, 2026 | 64.54M |
| September 15, 2026 | 65.71M |
| September 14, 2026 | 66.29M |
| September 11, 2026 | 65.71M |
| September 10, 2026 | 65.12M |
| September 09, 2026 | 68.03M |
| September 08, 2026 | 69.19M |
| September 04, 2026 | 70.36M |
| September 03, 2026 | 70.94M |
| September 02, 2026 | 70.94M |
| September 01, 2026 | 69.78M |
| August 31, 2026 | 70.94M |
| August 28, 2026 | 69.78M |
| Date | Value |
|---|---|
| August 27, 2026 | 70.36M |
| August 26, 2026 | 70.94M |
| August 25, 2026 | 71.52M |
| August 24, 2026 | 70.65M |
| August 21, 2026 | 70.94M |
| August 20, 2026 | 70.36M |
| August 19, 2026 | 71.52M |
| August 18, 2026 | 69.78M |
| August 17, 2026 | 69.19M |
| August 14, 2026 | 71.52M |
| August 13, 2026 | 72.10M |
| August 12, 2026 | 69.19M |
| August 11, 2026 | 71.52M |
| August 10, 2026 | 71.52M |
| August 07, 2026 | 72.94M |
| August 06, 2026 | 73.52M |
| August 05, 2026 | 72.94M |
| August 04, 2026 | 71.21M |
| August 03, 2026 | 66.58M |
| July 31, 2026 | 67.73M |
| July 30, 2026 | 69.47M |
| July 29, 2026 | 68.89M |
| July 28, 2026 | 69.18M |
| July 27, 2026 | 68.31M |
| July 24, 2026 | 68.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 95.52M |
| Fortress Biotech, Inc. | 67.62M |
| Kura Oncology, Inc. | 947.36M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
Market Cap Related Metrics
| PE Ratio | 10.91 |
| PS Ratio | 1.599 |
| Price to Book Value | 1.565 |
| Price to Free Cash Flow | 3.508 |
| Price | 1.19 |
| Earnings Yield | 9.17% |
| Operating PE Ratio | 26.64 |
| Normalized PE Ratio | 10.21 |